Encourages translational activities and small clinical studies for neural devices to address disorders affecting the nervous system; includes prototype development, safety testing, and clinical validation.
NIH supports development of next-generation diagnostic and therapeutic devices aligned with its brain research and addiction initiatives, preparing them for first-in-human trials; clinical trials are not allowed.
NIH plans a milestone-driven award supporting planning and early to definitive clinical trials across biomedical and other interventions for up to 7 years; applications are not yet being accepted.
Funding for early-stage trials testing drugs or devices for mental disorder treatment, focusing on clinical effects and underlying mechanisms.
Supports investigator-initiated clinical trials for neurological disorders, from early exploratory studies to Phase 3 confirmatory and comparative effectiveness trials.
NIH supports development, testing, and clinical feasibility studies of therapeutic and diagnostic devices for nervous or neuromuscular disorders through milestone-driven cooperative agreements.